Home › Funds › Newtyn Management, LLC › INDV

Newtyn Management, LLC position in INDV

INDIVIOR PHARMACEUTICALS INC · Health Care

Newtyn Management, LLC reported holding 1,305,795 shares of INDV (INDIVIOR PHARMACEUTICALS INC) in its Q2 2026 13F filing — a position valued at US$53.6M, representing 6.69% of its reported portfolio and ranking #3 among its reported holdings. Newtyn Management, LLC has disclosed INDV holdings in 8 of the last 8 reported quarters, going back to Q3 2024.

Latest position (Q2 2026)1.31M sh
Reported value held$53.58M
Portfolio Weight6.69%
First reportedQ3 2024
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Newtyn Management, LLC's INDV position evolved

Newtyn Management, LLC first disclosed a stake in INDV in Q3 2024 at 868,105 shares (US$8.5M). The position peaked in Q3 2025 at 4,200,000 shares, worth US$101.3M. Across 8 filings, Newtyn Management, LLC increased the stake 4 time(s), trimmed it 3 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 1,305,795 shares valued at US$53.6M — a reduction of -694,205 shares quarter over quarter.. Notable position changes include a 62% increase in Q4 2024 (shares fell 23% over the following quarter), a 58% increase in Q2 2025 (shares rose 64% over the following quarter), a 61% increase in Q3 2025 (shares rose 49% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2024 868.11K $8.46M New
Q4 2024 1.41M $17.48M Add
Q1 2025 1.65M $15.73M Add
Q2 2025 2.61M $38.43M Add
Q3 2025 4.20M $101.26M Add
Q4 2025 2.53M $90.94M Reduce
Q1 2026 2.00M $60.96M Reduce
Q2 2026 1.31M $53.58M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About INDV and 13F data

INDV (INDIVIOR PHARMACEUTICALS INC) is a Health Care company. 53 other funds we track also report a position in INDV — the largest reported positions include OAKTREE CAPITAL MANAGEMENT LP (US$251.4M), Two Seas Capital LP (US$131.6M), Madison Avenue Partners, LP (US$117.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding INDV

All INDV fund holders →

FAQ

How long has Newtyn Management, LLC held INDV?

Newtyn Management, LLC has disclosed INDV holdings in 8 of the last 8 reported quarters, going back to Q3 2024.

What is Newtyn Management, LLC's current position in INDV?

As of Q2 2026, Newtyn Management, LLC holds 1.31M shares of INDV (INDIVIOR PHARMACEUTICALS INC), valued at $53.58M, representing 6.69% of its reported portfolio and ranking #3.

Has Newtyn Management, LLC been buying or selling INDV?

In the latest 13F filing (Q2 2026), Newtyn Management, LLC reduced its position in INDV. The position peaked in Q3 2025 at 4.20M shares.

Which other funds hold INDV?

Other major institutional holders of INDV include OAKTREE CAPITAL MANAGEMENT LP, Two Seas Capital LP, Madison Avenue Partners, LP, among 53 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.